APO Research
Talk to an analyst

APO RESEARCH · REPORT

Irbesartan

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Irbesartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025198 pages

Choose your research edition.

Industry ResearchIrbesartan Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Irbesartan Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Irbesartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Irbesartan Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Irbesartan Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Irbesartan market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Irbesartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Irbesartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Irbesartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Irbesartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Irbesartan include Angita Pharma, Apotex, Auro Pharma, Avanstra, BMS, Hanall, Shionogi, Sumitomo Dainippon Pharma and Taj Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Irbesartan market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Irbesartan and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Irbesartan sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Irbesartan market size, projected growth trends, production technologies, key applications, and end-use industries.

Irbesartan Segment by Company

Angita Pharma

Apotex

Auro Pharma

Avanstra

BMS

Hanall

Shionogi

Sumitomo Dainippon Pharma

Taj Pharmaceuticals

Verdant Life Sciences

Jiangsu Hengrui Medicine

Jiangsu Wangao Pharmaceutical

CTTQ

Novartis

Sanofi

Teva

Tianjin Huairen Pharmaceutical

Xiansheng Pharmaceutical

Yuanhe Pharmaceutical

Zhejiang Ainuo Pharmaceutical

Zhejiang Huahai Pharmaceutical

Zhuhai Rundu Pharma

Irbesartan Segment by Type

Combination Drugs

Prescribed Drugs

Irbesartan Segment by Application

Heart Failure

Fibrous Fibrillation

Kidney Disease

Hyperlipidemia

High Blood Pressure

Other

Irbesartan Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irbesartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Irbesartan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irbesartan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Irbesartan market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Irbesartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Irbesartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Irbesartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Irbesartan Industry Trends Table 2. Irbesartan Industry Drivers Table 3. Irbesartan Industry Opportunities and Challenges Table 4. Irbesartan Industry Restraints Table 5. Global Irbesartan Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Irbesartan Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Irbesartan Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Irbesartan Sales Market Share by Manufacturers Table 9. Global Irbesartan Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Irbesartan Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Irbesartan Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Irbesartan Manufacturers, Product Type & Application Table 13. Global Irbesartan Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Irbesartan by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Combination Drugs Table 17. Major Manufacturers of Prescribed Drugs Table 18. Global Irbesartan Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 19. Global Irbesartan Sales by Type (2021-2026) & (Kg) Table 20. Global Irbesartan Sales by Type (2027-2032) & (Kg) Table 21. Global Irbesartan Sales Market Share by Type (2021-2026) Table 22. Global Irbesartan Sales Market Share by Type (2027-2032) Table 23. Global Irbesartan Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 24. Global Irbesartan Revenue by Type (2021-2026) & (Kg) Table 25. Global Irbesartan Revenue by Type (2027-2032) & (Kg) Table 26. Global Irbesartan Revenue Market Share by Type (2021-2026) Table 27. Global Irbesartan Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Heart Failure Table 29. Major Manufacturers of Fibrous Fibrillation Table 30. Major Manufacturers of Kidney Disease Table 31. Major Manufacturers of Hyperlipidemia Table 32. Major Manufacturers of High Blood Pressure Table 33. Major Manufacturers of Other Table 34. Global Irbesartan Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 35. Global Irbesartan Sales by Application (2021-2026) & (Kg) Table 36. Global Irbesartan Sales by Application (2027-2032) & (Kg) Table 37. Global Irbesartan Sales Market Share by Application (2021-2026) Table 38. Global Irbesartan Sales Market Share by Application (2027-2032) Table 39. Global Irbesartan Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 40. Global Irbesartan Revenue by Application (2021-2026) & (Kg) Table 41. Global Irbesartan Revenue by Application (2027-2032) & (Kg) Table 42. Global Irbesartan Revenue Market Share by Application (2021-2026) Table 43. Global Irbesartan Revenue Market Share by Application (2027-2032) Table 44. Global Irbesartan Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 45. Global Irbesartan Sales by Region (2021-2026) & (Kg) Table 46. Global Irbesartan Sales Market Share by Region (2021-2026) Table 47. Global Irbesartan Sales Forecasted by Region (2027-2032) & (Kg) Table 48. Global Irbesartan Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Irbesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 50. North America Irbesartan Sales by Country (2021-2026) & (Kg) Table 51. North America Irbesartan Sales by Country (2027-2032) & (Kg) Table 52. Europe Irbesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 53. Europe Irbesartan Sales by Country (2021-2026) & (Kg) Table 54. Europe Irbesartan Sales by Country (2027-2032) & (Kg) Table 55. Asia Pacific Irbesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Asia Pacific Irbesartan Sales by Country (2021-2026) & (Kg) Table 57. Asia Pacific Irbesartan Sales by Country (2027-2032) & (Kg) Table 58. South America, Middle East and Africa Irbesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 59. South America, Middle East and Africa Irbesartan Sales by Country (2021-2026) & (Kg) Table 60. South America, Middle East and Africa Irbesartan Sales by Country (2027-2032) & (Kg) Table 61. Global Irbesartan Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Irbesartan Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Irbesartan Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Irbesartan Revenue Market Share by Region (2021-2026) Table 65. Global Irbesartan Revenue Market Share by Region (2027-2032) Table 66. Angita Pharma Company Information Table 67. Angita Pharma Business Overview Table 68. Angita Pharma Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Angita Pharma Irbesartan Product Portfolio Table 70. Angita Pharma Recent Development Table 71. Apotex Company Information Table 72. Apotex Business Overview Table 73. Apotex Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Apotex Irbesartan Product Portfolio Table 75. Apotex Recent Development Table 76. Auro Pharma Company Information Table 77. Auro Pharma Business Overview Table 78. Auro Pharma Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Auro Pharma Irbesartan Product Portfolio Table 80. Auro Pharma Recent Development Table 81. Avanstra Company Information Table 82. Avanstra Business Overview Table 83. Avanstra Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Avanstra Irbesartan Product Portfolio Table 85. Avanstra Recent Development Table 86. BMS Company Information Table 87. BMS Business Overview Table 88. BMS Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. BMS Irbesartan Product Portfolio Table 90. BMS Recent Development Table 91. Hanall Company Information Table 92. Hanall Business Overview Table 93. Hanall Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Hanall Irbesartan Product Portfolio Table 95. Hanall Recent Development Table 96. Shionogi Company Information Table 97. Shionogi Business Overview Table 98. Shionogi Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Shionogi Irbesartan Product Portfolio Table 100. Shionogi Recent Development Table 101. Sumitomo Dainippon Pharma Company Information Table 102. Sumitomo Dainippon Pharma Business Overview Table 103. Sumitomo Dainippon Pharma Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Sumitomo Dainippon Pharma Irbesartan Product Portfolio Table 105. Sumitomo Dainippon Pharma Recent Development Table 106. Taj Pharmaceuticals Company Information Table 107. Taj Pharmaceuticals Business Overview Table 108. Taj Pharmaceuticals Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Taj Pharmaceuticals Irbesartan Product Portfolio Table 110. Taj Pharmaceuticals Recent Development Table 111. Verdant Life Sciences Company Information Table 112. Verdant Life Sciences Business Overview Table 113. Verdant Life Sciences Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Verdant Life Sciences Irbesartan Product Portfolio Table 115. Verdant Life Sciences Recent Development Table 116. Jiangsu Hengrui Medicine Company Information Table 117. Jiangsu Hengrui Medicine Business Overview Table 118. Jiangsu Hengrui Medicine Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Jiangsu Hengrui Medicine Irbesartan Product Portfolio Table 120. Jiangsu Hengrui Medicine Recent Development Table 121. Jiangsu Wangao Pharmaceutical Company Information Table 122. Jiangsu Wangao Pharmaceutical Business Overview Table 123. Jiangsu Wangao Pharmaceutical Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Jiangsu Wangao Pharmaceutical Irbesartan Product Portfolio Table 125. Jiangsu Wangao Pharmaceutical Recent Development Table 126. CTTQ Company Information Table 127. CTTQ Business Overview Table 128. CTTQ Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. CTTQ Irbesartan Product Portfolio Table 130. CTTQ Recent Development Table 131. Novartis Company Information Table 132. Novartis Business Overview Table 133. Novartis Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Novartis Irbesartan Product Portfolio Table 135. Novartis Recent Development Table 136. Sanofi Company Information Table 137. Sanofi Business Overview Table 138. Sanofi Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Sanofi Irbesartan Product Portfolio Table 140. Sanofi Recent Development Table 141. Teva Company Information Table 142. Teva Business Overview Table 143. Teva Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Teva Irbesartan Product Portfolio Table 145. Teva Recent Development Table 146. Tianjin Huairen Pharmaceutical Company Information Table 147. Tianjin Huairen Pharmaceutical Business Overview Table 148. Tianjin Huairen Pharmaceutical Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Tianjin Huairen Pharmaceutical Irbesartan Product Portfolio Table 150. Tianjin Huairen Pharmaceutical Recent Development Table 151. Xiansheng Pharmaceutical Company Information Table 152. Xiansheng Pharmaceutical Business Overview Table 153. Xiansheng Pharmaceutical Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Xiansheng Pharmaceutical Irbesartan Product Portfolio Table 155. Xiansheng Pharmaceutical Recent Development Table 156. Yuanhe Pharmaceutical Company Information Table 157. Yuanhe Pharmaceutical Business Overview Table 158. Yuanhe Pharmaceutical Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Yuanhe Pharmaceutical Irbesartan Product Portfolio Table 160. Yuanhe Pharmaceutical Recent Development Table 161. Zhejiang Ainuo Pharmaceutical Company Information Table 162. Zhejiang Ainuo Pharmaceutical Business Overview Table 163. Zhejiang Ainuo Pharmaceutical Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Zhejiang Ainuo Pharmaceutical Irbesartan Product Portfolio Table 165. Zhejiang Ainuo Pharmaceutical Recent Development Table 166. Zhejiang Huahai Pharmaceutical Company Information Table 167. Zhejiang Huahai Pharmaceutical Business Overview Table 168. Zhejiang Huahai Pharmaceutical Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Zhejiang Huahai Pharmaceutical Irbesartan Product Portfolio Table 170. Zhejiang Huahai Pharmaceutical Recent Development Table 171. Zhuhai Rundu Pharma Company Information Table 172. Zhuhai Rundu Pharma Business Overview Table 173. Zhuhai Rundu Pharma Irbesartan Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. Zhuhai Rundu Pharma Irbesartan Product Portfolio Table 175. Zhuhai Rundu Pharma Recent Development Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Irbesartan Distributors List Table 179. Irbesartan Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Irbesartan Product Image Figure 2. Global Irbesartan Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Irbesartan Market Size (2021-2032) & (US$ Million) Figure 4. Global Irbesartan Sales (2021-2032) & (Kg) Figure 5. Global Irbesartan Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Irbesartan Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Combination Drugs Image Figure 9. Prescribed Drugs Image Figure 10. Global Irbesartan Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 11. Global Irbesartan Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Irbesartan Sales Market Share by Type (2021-2032) Figure 13. Global Irbesartan Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Irbesartan Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Irbesartan Revenue Market Share by Type (2021-2032) Figure 16. Heart Failure Image Figure 17. Fibrous Fibrillation Image Figure 18. Kidney Disease Image Figure 19. Hyperlipidemia Image Figure 20. High Blood Pressure Image Figure 21. Other Image Figure 22. Global Irbesartan Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 23. Global Irbesartan Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Irbesartan Sales Market Share by Application (2021-2032) Figure 25. Global Irbesartan Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 26. Global Irbesartan Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Irbesartan Revenue Market Share by Application (2021-2032) Figure 28. North America Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 29. North America Irbesartan Sales Market Share by Country (2021-2032) Figure 30. U.S. Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Canada Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 32. Mexico Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 33. Europe Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 34. Europe Irbesartan Sales Market Share by Country (2021-2032) Figure 35. Germany Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 36. France Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 37. U.K. Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Italy Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 39. Netherlands Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 40. Asia Pacific Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 41. Asia Pacific Irbesartan Sales Market Share by Country (2021-2032) Figure 42. China Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 43. Japan Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 44. South Korea Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 45. Southeast Asia Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 46. India Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 47. Australia Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 48. South America, Middle East and Africa Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 49. South America, Middle East and Africa Irbesartan Sales Market Share by Country (2021-2032) Figure 50. Brazil Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 51. South Africa Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 52. Saudi Arabia Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 53. Turkey Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Argentina Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 55. UAE Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 56. Egypt Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 57. Chile Irbesartan Sales and Growth Rate (2021-2032) & (Kg) Figure 58. Global Irbesartan Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Irbesartan Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Irbesartan Revenue (2021-2032) & (US$ Million) Figure 61. North America Irbesartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Irbesartan Revenue (2021-2032) & (US$ Million) Figure 63. Europe Irbesartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Irbesartan Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Irbesartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Irbesartan Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Irbesartan Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Irbesartan Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Irbesartan Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Combination Drugs
  • Prescribed Drugs
Applications
  • Heart Failure
  • Fibrous Fibrillation
  • Kidney Disease
  • Hyperlipidemia
  • High Blood Pressure
  • Other
Companies covered
  • Angita Pharma
  • Apotex
  • Auro Pharma
  • Avanstra
  • BMS
  • Hanall
  • Shionogi
  • Sumitomo Dainippon Pharma
  • Taj Pharmaceuticals
  • Verdant Life Sciences
  • Jiangsu Hengrui Medicine
  • Jiangsu Wangao Pharmaceutical
  • CTTQ
  • Novartis
  • Sanofi
  • Teva
  • Tianjin Huairen Pharmaceutical
  • Xiansheng Pharmaceutical
  • Yuanhe Pharmaceutical
  • Zhejiang Ainuo Pharmaceutical
  • Zhejiang Huahai Pharmaceutical
  • Zhuhai Rundu Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Irbesartan Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Irbesartan Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Irbesartan Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Irbesartan Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Irbesartan Market Dynamics
  1. 2.1 Irbesartan Industry Trends
  2. 2.2 Irbesartan Industry Drivers
  3. 2.3 Irbesartan Industry Opportunities and Challenges
  4. 2.4 Irbesartan Industry Restraints
3 Irbesartan Market by Manufacturers
  1. 3.1 Global Irbesartan Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Irbesartan Sales by Manufacturers (2021-2026)
  3. 3.3 Global Irbesartan Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Irbesartan Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Irbesartan Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Irbesartan Manufacturers, Product Type & Application
  7. 3.7 Global Irbesartan Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Irbesartan Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Irbesartan Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Irbesartan Tier 1, Tier 2, and Tier 3
4 Irbesartan Market by Type
  1. 4.1 Irbesartan Type Introduction
  2. 4.1.1 Combination Drugs
  3. 4.1.2 Prescribed Drugs
  4. 4.2 Global Irbesartan Sales by Type
  5. 4.2.1 Global Irbesartan Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Irbesartan Sales by Type (2021-2032)
  7. 4.2.3 Global Irbesartan Sales Market Share by Type (2021-2032)
  8. 4.3 Global Irbesartan Revenue by Type
  9. 4.3.1 Global Irbesartan Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Irbesartan Revenue by Type (2021-2032)
  11. 4.3.3 Global Irbesartan Revenue Market Share by Type (2021-2032)
5 Irbesartan Market by Application
  1. 5.1 Irbesartan Application Introduction
  2. 5.1.1 Heart Failure
  3. 5.1.2 Fibrous Fibrillation
  4. 5.1.3 Kidney Disease
  5. 5.1.4 Hyperlipidemia
  6. 5.1.5 High Blood Pressure
  7. 5.1.6 Other
  8. 5.2 Global Irbesartan Sales by Application
  9. 5.2.1 Global Irbesartan Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Irbesartan Sales by Application (2021-2032)
  11. 5.2.3 Global Irbesartan Sales Market Share by Application (2021-2032)
  12. 5.3 Global Irbesartan Revenue by Application
  13. 5.3.1 Global Irbesartan Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Irbesartan Revenue by Application (2021-2032)
  15. 5.3.3 Global Irbesartan Revenue Market Share by Application (2021-2032)
6 Global Irbesartan Sales by Region
  1. 6.1 Global Irbesartan Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Irbesartan Sales by Region (2021-2032)
  3. 6.2.1 Global Irbesartan Sales by Region (2021-2026)
  4. 6.2.2 Global Irbesartan Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Irbesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Irbesartan Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Irbesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Irbesartan Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Irbesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Irbesartan Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Irbesartan Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Irbesartan Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Irbesartan Revenue by Region
  1. 7.1 Global Irbesartan Revenue by Region
  2. 7.1.1 Global Irbesartan Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Irbesartan Revenue by Region (2021-2026)
  4. 7.1.3 Global Irbesartan Revenue by Region (2027-2032)
  5. 7.1.4 Global Irbesartan Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Irbesartan Revenue (2021-2032)
  8. 7.2.2 North America Irbesartan Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Irbesartan Revenue (2021-2032)
  11. 7.3.2 Europe Irbesartan Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Irbesartan Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Irbesartan Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Irbesartan Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Irbesartan Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Angita Pharma
  2. 8.1.1 Angita Pharma Company Information
  3. 8.1.2 Angita Pharma Business Overview
  4. 8.1.3 Angita Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Angita Pharma Irbesartan Product Portfolio
  6. 8.1.5 Angita Pharma Recent Developments
  7. 8.2 Apotex
  8. 8.2.1 Apotex Company Information
  9. 8.2.2 Apotex Business Overview
  10. 8.2.3 Apotex Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Apotex Irbesartan Product Portfolio
  12. 8.2.5 Apotex Recent Developments
  13. 8.3 Auro Pharma
  14. 8.3.1 Auro Pharma Company Information
  15. 8.3.2 Auro Pharma Business Overview
  16. 8.3.3 Auro Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Auro Pharma Irbesartan Product Portfolio
  18. 8.3.5 Auro Pharma Recent Developments
  19. 8.4 Avanstra
  20. 8.4.1 Avanstra Company Information
  21. 8.4.2 Avanstra Business Overview
  22. 8.4.3 Avanstra Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Avanstra Irbesartan Product Portfolio
  24. 8.4.5 Avanstra Recent Developments
  25. 8.5 BMS
  26. 8.5.1 BMS Company Information
  27. 8.5.2 BMS Business Overview
  28. 8.5.3 BMS Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BMS Irbesartan Product Portfolio
  30. 8.5.5 BMS Recent Developments
  31. 8.6 Hanall
  32. 8.6.1 Hanall Company Information
  33. 8.6.2 Hanall Business Overview
  34. 8.6.3 Hanall Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hanall Irbesartan Product Portfolio
  36. 8.6.5 Hanall Recent Developments
  37. 8.7 Shionogi
  38. 8.7.1 Shionogi Company Information
  39. 8.7.2 Shionogi Business Overview
  40. 8.7.3 Shionogi Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shionogi Irbesartan Product Portfolio
  42. 8.7.5 Shionogi Recent Developments
  43. 8.8 Sumitomo Dainippon Pharma
  44. 8.8.1 Sumitomo Dainippon Pharma Company Information
  45. 8.8.2 Sumitomo Dainippon Pharma Business Overview
  46. 8.8.3 Sumitomo Dainippon Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sumitomo Dainippon Pharma Irbesartan Product Portfolio
  48. 8.8.5 Sumitomo Dainippon Pharma Recent Developments
  49. 8.9 Taj Pharmaceuticals
  50. 8.9.1 Taj Pharmaceuticals Company Information
  51. 8.9.2 Taj Pharmaceuticals Business Overview
  52. 8.9.3 Taj Pharmaceuticals Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Taj Pharmaceuticals Irbesartan Product Portfolio
  54. 8.9.5 Taj Pharmaceuticals Recent Developments
  55. 8.10 Verdant Life Sciences
  56. 8.10.1 Verdant Life Sciences Company Information
  57. 8.10.2 Verdant Life Sciences Business Overview
  58. 8.10.3 Verdant Life Sciences Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Verdant Life Sciences Irbesartan Product Portfolio
  60. 8.10.5 Verdant Life Sciences Recent Developments
  61. 8.11 Jiangsu Hengrui Medicine
  62. 8.11.1 Jiangsu Hengrui Medicine Company Information
  63. 8.11.2 Jiangsu Hengrui Medicine Business Overview
  64. 8.11.3 Jiangsu Hengrui Medicine Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Jiangsu Hengrui Medicine Irbesartan Product Portfolio
  66. 8.11.5 Jiangsu Hengrui Medicine Recent Developments
  67. 8.12 Jiangsu Wangao Pharmaceutical
  68. 8.12.1 Jiangsu Wangao Pharmaceutical Company Information
  69. 8.12.2 Jiangsu Wangao Pharmaceutical Business Overview
  70. 8.12.3 Jiangsu Wangao Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Jiangsu Wangao Pharmaceutical Irbesartan Product Portfolio
  72. 8.12.5 Jiangsu Wangao Pharmaceutical Recent Developments
  73. 8.13 CTTQ
  74. 8.13.1 CTTQ Company Information
  75. 8.13.2 CTTQ Business Overview
  76. 8.13.3 CTTQ Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CTTQ Irbesartan Product Portfolio
  78. 8.13.5 CTTQ Recent Developments
  79. 8.14 Novartis
  80. 8.14.1 Novartis Company Information
  81. 8.14.2 Novartis Business Overview
  82. 8.14.3 Novartis Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Novartis Irbesartan Product Portfolio
  84. 8.14.5 Novartis Recent Developments
  85. 8.15 Sanofi
  86. 8.15.1 Sanofi Company Information
  87. 8.15.2 Sanofi Business Overview
  88. 8.15.3 Sanofi Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sanofi Irbesartan Product Portfolio
  90. 8.15.5 Sanofi Recent Developments
  91. 8.16 Teva
  92. 8.16.1 Teva Company Information
  93. 8.16.2 Teva Business Overview
  94. 8.16.3 Teva Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Teva Irbesartan Product Portfolio
  96. 8.16.5 Teva Recent Developments
  97. 8.17 Tianjin Huairen Pharmaceutical
  98. 8.17.1 Tianjin Huairen Pharmaceutical Company Information
  99. 8.17.2 Tianjin Huairen Pharmaceutical Business Overview
  100. 8.17.3 Tianjin Huairen Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Tianjin Huairen Pharmaceutical Irbesartan Product Portfolio
  102. 8.17.5 Tianjin Huairen Pharmaceutical Recent Developments
  103. 8.18 Xiansheng Pharmaceutical
  104. 8.18.1 Xiansheng Pharmaceutical Company Information
  105. 8.18.2 Xiansheng Pharmaceutical Business Overview
  106. 8.18.3 Xiansheng Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Xiansheng Pharmaceutical Irbesartan Product Portfolio
  108. 8.18.5 Xiansheng Pharmaceutical Recent Developments
  109. 8.19 Yuanhe Pharmaceutical
  110. 8.19.1 Yuanhe Pharmaceutical Company Information
  111. 8.19.2 Yuanhe Pharmaceutical Business Overview
  112. 8.19.3 Yuanhe Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Yuanhe Pharmaceutical Irbesartan Product Portfolio
  114. 8.19.5 Yuanhe Pharmaceutical Recent Developments
  115. 8.20 Zhejiang Ainuo Pharmaceutical
  116. 8.20.1 Zhejiang Ainuo Pharmaceutical Company Information
  117. 8.20.2 Zhejiang Ainuo Pharmaceutical Business Overview
  118. 8.20.3 Zhejiang Ainuo Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Zhejiang Ainuo Pharmaceutical Irbesartan Product Portfolio
  120. 8.20.5 Zhejiang Ainuo Pharmaceutical Recent Developments
  121. 8.21 Zhejiang Huahai Pharmaceutical
  122. 8.21.1 Zhejiang Huahai Pharmaceutical Company Information
  123. 8.21.2 Zhejiang Huahai Pharmaceutical Business Overview
  124. 8.21.3 Zhejiang Huahai Pharmaceutical Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Zhejiang Huahai Pharmaceutical Irbesartan Product Portfolio
  126. 8.21.5 Zhejiang Huahai Pharmaceutical Recent Developments
  127. 8.22 Zhuhai Rundu Pharma
  128. 8.22.1 Zhuhai Rundu Pharma Company Information
  129. 8.22.2 Zhuhai Rundu Pharma Business Overview
  130. 8.22.3 Zhuhai Rundu Pharma Irbesartan Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Zhuhai Rundu Pharma Irbesartan Product Portfolio
  132. 8.22.5 Zhuhai Rundu Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Irbesartan Value Chain Analysis
  2. 9.1.1 Irbesartan Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Irbesartan Production Mode & Process
  6. 9.2 Irbesartan Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Irbesartan Distributors
  9. 9.2.3 Irbesartan Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst